Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome

Clinical trial NCT00030550 · COMPLETED

Trial details

NCT number: NCT00030550
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2001-09-01
Primary completion: 2003-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.